THE INVESTOR CONFERENCE FOR INNOVATORS

January 13–15, 2025 | San Francisco, CAJanuary 21–22, 2025 | Virtual

John McDonald
Corporate Vice President, Global Head of Business Development and M&A at Novo Nordisk
Speaker

Agenda Sessions

Pharma Perspective: The Current Partnering and Business Development Landscape
Jan 08, 16:30
View Session

At this event

Prev

Next

Wyatt McDonnell

Infinimmune, Inc.